These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26320525)

  • 21. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Locomotive syndrome and frailty. Osteoporosis as an underlying disorder in the locomotive syndrome].
    Hagino H
    Clin Calcium; 2012 Apr; 22(4):41-8. PubMed ID: 22460510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defining high risk of osteoporotic fracture: a cross talk between clinical experience and guidelines recommendations.
    Casado E; Malouf J; Caamaño MM; Salas E; Sánchez-Bursón JM; Rentero ML; Herrero-Beaumont G
    J Clin Rheumatol; 2011 Aug; 17(5 Suppl 3):S59-66. PubMed ID: 23640502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Half the burden of fragility fractures in the community occur in women without osteoporosis. When is fracture prevention cost-effective?
    Sanders KM; Nicholson GC; Watts JJ; Pasco JA; Henry MJ; Kotowicz MA; Seeman E
    Bone; 2006 May; 38(5):694-700. PubMed ID: 16507356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Managing elderly people's osteoporosis. Why? Who? How?
    Juby A
    Can Fam Physician; 1999 Jun; 45():1526-36. PubMed ID: 10386218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of two inexpensive postfracture osteoporosis interventions: results of a randomized trial.
    Majumdar SR; Lier DA; Leslie WD
    J Clin Endocrinol Metab; 2013 May; 98(5):1991-2000. PubMed ID: 23596140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-world challenges of treating osteoporosis.
    Owens G
    Am J Manag Care; 2011 May; 17 Suppl 6():S177-84. PubMed ID: 21882487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of osteoporosis in the elderly.
    Rizzoli R; Bruyere O; Cannata-Andia JB; Devogelaer J-; Lyritis G; Ringe JD; Vellas B; Reginster J-
    Curr Med Res Opin; 2009 Oct; 25(10):2373-87. PubMed ID: 19650751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rehabilitative approach in patients with vertebral fragility fracture.
    Riccio I; Tirelli A; Gimigliano F; Iolascon G; Gimigliano R
    Aging Clin Exp Res; 2013 Oct; 25 Suppl 1():S109-11. PubMed ID: 24046035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [On "2015 Guidelines for Prevention and Treatment of Osteoporosis". Lifestyle-related disease associated osteoporosis: Diabetes].
    Yamamoto M
    Clin Calcium; 2015 Sep; 25(9):1319-27. PubMed ID: 26320532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-pharmacological means to prevent fractures among older adults.
    Kannus P; Uusi-Rasi K; Palvanen M; Parkkari J
    Ann Med; 2005; 37(4):303-10. PubMed ID: 16019730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bridging the osteoporosis treatment gap: performance and cost-effectiveness of a fracture liaison service.
    Yates CJ; Chauchard MA; Liew D; Bucknill A; Wark JD
    J Clin Densitom; 2015; 18(2):150-6. PubMed ID: 25797867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outpatient management of the elderly patient following fragility hip fracture.
    Sanders S; Geraci SA
    Am J Med; 2011 May; 124(5):408-10. PubMed ID: 21531228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteoporosis and osteoporotic fracture occurrence and prevention in the elderly: a geriatric perspective.
    Boonen S; Dejaeger E; Vanderschueren D; Venken K; Bogaerts A; Verschueren S; Milisen K
    Best Pract Res Clin Endocrinol Metab; 2008 Oct; 22(5):765-85. PubMed ID: 19028356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A meta-analysis of osteoporotic fracture risk with medication nonadherence.
    Ross S; Samuels E; Gairy K; Iqbal S; Badamgarav E; Siris E
    Value Health; 2011 Jun; 14(4):571-81. PubMed ID: 21669382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New horizons in fracture risk assessment.
    Aspray TJ
    Age Ageing; 2013 Sep; 42(5):548-54. PubMed ID: 23892830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current understanding of osteoporosis according to the position of the World Health Organization (WHO) and International Osteoporosis Foundation.
    Czerwiński E; Badurski JE; Marcinowska-Suchowierska E; Osieleniec J
    Ortop Traumatol Rehabil; 2007; 9(4):337-56. PubMed ID: 17882114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The setting of the treatment target of osteoporosis].
    Soen S
    Clin Calcium; 2014 Jan; 24(1):19-24. PubMed ID: 24369276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Epidemiology of bone and joint disease - the present and future - . Risk and prevention/treatment of fractures associated with lifestyle-related diseases].
    Yamauchi M
    Clin Calcium; 2014 May; 24(5):733-42. PubMed ID: 24769685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.